Mode
Text Size
Log in / Sign up

Review of ivermectin MDA for onchocerciasis and hookworm co-infections in endemic regionsIvermectin helps clear hookworm even when people also carry river blindness

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider integrated strategies for onchocerciasis and hookworm co-infections, noting gaps in immunological data.

This is a narrative review that synthesizes evidence on integrated control of onchocerciasis and soil-transmitted helminths, focusing on co-infected populations in Onchocerca volvulus endemic regions. The scope includes preventative chemotherapy, population surveillance, post-elimination vector surveillance strategies, and Mass Drug Administration (MDA) with ivermectin.

The authors report a positive impact of MDA with ivermectin on hookworm co-infections. However, they note notable gaps in human immunological studies regarding the impact of onchocerciasis elimination in co-infected populations.

Key limitations acknowledged by the authors include the limited availability of comprehensive data on the immunological interactions between O. volvulus and other neglected tropical diseases, as well as gaps in human immunological studies. The review does not report specific effect sizes, p-values, confidence intervals, or sample sizes.

Practice relevance emphasizes the need for integrated control strategies and diagnostic tools to identify multiple diseases endemic to a particular region. The authors suggest that these approaches may support broader elimination efforts, but the evidence base remains incomplete.

People living in areas with river blindness often carry other parasites too. This review looked at how common treatments work when multiple infections are present. The focus was on populations already infected with Onchocerca volvulus who also had soil-transmitted helminths like hookworm.

The analysis found that mass drug administration with ivermectin has a positive impact on hookworm infections in these co-infected groups. This suggests the standard treatment helps clear up the secondary parasite effectively. However, the review also noted that there are notable gaps in human immunological studies. We simply do not have comprehensive data on how these different diseases interact inside the human body.

Experts say we need integrated control strategies and better diagnostic tools to identify multiple diseases in the same region. Without these tools, it is hard to manage complex infections fully. While the treatment works, the lack of detailed immune data means we are flying somewhat blind on exactly how the body fights these combined threats.

What this means for you:
Ivermectin helps clear hookworm in people with river blindness, but we need more data on how these infections interact.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
Onchocerciasis is one of the neglected tropical diseases targeted by the World Health Organization (WHO) for elimination through preventative chemotherapy, population surveillance, and post-elimination vector surveillance strategies. Several Onchocerca volvulus endemic regions suffer from co-infections that create challenges for preventative chemotherapy which ultimately hinders global elimination efforts. Though co-infection dynamics between onchocerciasis and other neglected tropical diseases are described in literature, this review demonstrates notable gaps in human immunological studies with regard to the impacts of onchocerciasis elimination in co-infected populations. In regions where multiple NTDs coexist healthcare workers are faced with diagnostic and treatment challenges that underscore the need for integrated control strategies and diagnostic tools to identify multiple diseases endemic to a particular region. Though treatment and control measures have demonstrated challenges, a positive aspect was noted in this review regarding co-infection of onchocerciasis and soil-transmitted helminths (STH), wherein Mass Drug Administration (MDA) with ivermectin for treatment of onchocerciasis had a positive impact in treating hookworm co-infections. With limited availability of comprehensive data on the immunological interactions between O. volvulus and other neglected tropical diseases there is a need for further research to determine the necessary steps required to reach onchocerciasis elimination in foci that currently face treatment challenges and complications.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.